A recent study showed that somatic mutations of well-known cancer driver genes, found in circulating tumour DNA, can be detected in the bloodstream of patients with different cancer types. This makes blood screening a potential approach for non-invasive early cancer detection. The few genes tested in that study, however, are by themselves insuf-ficient to identify the cancer type. Here, we investigated the extent to which mutations in general can distinguish between different cancer types. Using data from the cBioPortal for Cancer Genomics, we examined the somatic mutations in 5929 tumour samples spanning 22 cancer types. We cast the data into a binary matrix, using “1 ” and “0 ” to indicate the presence or absence of somatic mutations in a...
In cancer, the primary tumour's organ of origin and histopathology are the strongest determinants of...
Cancer arises from the accumulation of particular somatic genomic variants known as drivers. New seq...
Motivation: The study of cancer genomes now routinely involves using next-generation sequencing tech...
Background Establishing the cancer type and site of origin is important in determining the most app...
AbstractSimultaneous multiclass classification of tumor types is essential for future clinical imple...
Cancer is a complex and deadly disease that is caused by genetic lesions in somatic cells. Further r...
Determining the cancer type and molecular subtype has important clinical implications. The primary s...
The identification and classification of different cancer type and feature gene subset selection are...
Copyright © 2015 Yukun Chen et al. This is an open access article distributed under the Creative Com...
In 2018, an estimated 1,762,450 new cases of cancer will be diagnosed in the United States and 606,8...
AbstractDifferential diagnosis among a group of histologically similar cancers poses a challenging p...
The catalogue of tumour-specific somatic mutations (SMs) is growing rapidly owing to the advent of n...
Biologists seek to identify a small number of significant features that are important, non-redundant...
The classification of different types of tumor is of great importance in cancer diagnosis and drug d...
In 70 % of the families with a high frequency of early-onset breast and/or ovarian cancer, BRCA1 or ...
In cancer, the primary tumour's organ of origin and histopathology are the strongest determinants of...
Cancer arises from the accumulation of particular somatic genomic variants known as drivers. New seq...
Motivation: The study of cancer genomes now routinely involves using next-generation sequencing tech...
Background Establishing the cancer type and site of origin is important in determining the most app...
AbstractSimultaneous multiclass classification of tumor types is essential for future clinical imple...
Cancer is a complex and deadly disease that is caused by genetic lesions in somatic cells. Further r...
Determining the cancer type and molecular subtype has important clinical implications. The primary s...
The identification and classification of different cancer type and feature gene subset selection are...
Copyright © 2015 Yukun Chen et al. This is an open access article distributed under the Creative Com...
In 2018, an estimated 1,762,450 new cases of cancer will be diagnosed in the United States and 606,8...
AbstractDifferential diagnosis among a group of histologically similar cancers poses a challenging p...
The catalogue of tumour-specific somatic mutations (SMs) is growing rapidly owing to the advent of n...
Biologists seek to identify a small number of significant features that are important, non-redundant...
The classification of different types of tumor is of great importance in cancer diagnosis and drug d...
In 70 % of the families with a high frequency of early-onset breast and/or ovarian cancer, BRCA1 or ...
In cancer, the primary tumour's organ of origin and histopathology are the strongest determinants of...
Cancer arises from the accumulation of particular somatic genomic variants known as drivers. New seq...
Motivation: The study of cancer genomes now routinely involves using next-generation sequencing tech...